Lv4
420 积分 2021-12-08 加入
Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease
6天前
已完结
Artificial intelligence in peptide-based drug design
16天前
已完结
Artificial intelligence in drug development
16天前
已完结
Trends in the drug target landscape for autoimmune diseases
16天前
已完结
STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology
1个月前
已完结
TYK2 as a Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases
1个月前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
1个月前
已完结
Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer
1个月前
已完结
HDAC6 as privileged target in drug discovery: A perspective
1个月前
已完结
The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease
1个月前
已完结
皖公网安备34019202002308
